AI assistant
ABBOTT LABORATORIES — Director's Dealing 2022
May 5, 2022
29777_dirs_2022-05-05_cf394f8a-01b6-4766-896d-c3a2e0098bc3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2022-05-03
Reporting Person: STARKS DANIEL J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-03 | Common shares without par value | S | 16822 | $112.5148 | Disposed | 7006678 | Direct |
| 2022-05-03 | Common shares without par value | S | 27055 | $113.2934 | Disposed | 6979623 | Direct |
| 2022-05-03 | Common shares without par value | S | 6123 | $114.8409 | Disposed | 6973500 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 258 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.875 to $112.86, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.885 to $113.86 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.885 to $114.33, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4: Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.